Global Home Hemodialysis Machine Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Global Home Hemodialysis Machine Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

The specific mechanism of hemodialysis is to use the diffusion and ultrafiltration effects of blood and dialysate to remove harmful substances from the blood to achieve the purpose of treating diseases. Among them, the dialysis membrane is very important. Generally speaking, it is composed of hollow fibers. The materials can be divided into cupro ammonia membrane, acetate membrane, blood imitation membrane, etc. Generally, water molecules with smaller molecules are rich in potassium, sodium, Calcium, magnesium and other ions can all pass through. Small molecules such as uric acid, urea, and creatinine in the blood pass through the dialysis membrane in one direction, and large molecular weight blood cells, proteins, fats, etc. are blocked by the dialysis membrane.

A hemodialysis machine is a device that pumps a patient's blood and dialysate through a dialyzer, which filters waste products from the blood. Home hemodialysis is a treatment method based on hemodialysis equipment and carried out by patients themselves under the guidance of professional medical personnel, or with the assistance of family members and caregivers. Home hemodialysis machine is a device used for home hemodialysis.

Market Overview:

The latest research study on the global Home Hemodialysis Machine market finds that the global Home Hemodialysis Machine market reached a value of USD 529.78 million in 2023. It’s expected that the market will achieve USD 849.34 million by 2029, exhibiting a CAGR of 8.18% during the forecast period.

The development of home hemodialysis

It is estimated that approximately 850 million people worldwide suffer from chronic kidney disease from various causes. The 2019 Global Health Assessment report released by the World Health Organization in 2020 shows that kidney disease has ranked among the top ten causes of death in the world. The disease burden caused by chronic kidney disease is increasing rapidly, and its disability and mortality rate ranks first among all chronic diseases. In China, the prevalence of chronic kidney disease is as high as 10.8%, the number of patients exceeds 100 million, and the awareness rate is only 12.5%. Chronic kidney disease is known as the silent killer due to its high prevalence, high cost, low awareness rate, and low cure rate. One in 10 adults worldwide suffers from chronic kidney disease (CKD). According to research data published in the medical journal The Lancet: the global average prevalence of CKD in 2017 was 9.1%, an increase of 29% compared to 1990; the number of deaths reached 1.23 million, an increase compared to 1990 41.5%. Data show that China has the largest number of CKD patients in the world. But what is even more shocking is that most patients do not know that they are sick, thus missing the best time for intervention, making the condition difficult to reverse. When CKD progresses to the end stage, it is end-stage renal disease (ESRD), also known as uremia, which requires dialysis treatment. The central dialysis model is the mainstream of the industry. Developed countries or regions such as the United States and Europe have experienced years of development, and dialysis centers are very densely distributed. However, as the number of dialysis patients increases, the disadvantages of central dialysis treatment begin to become apparent. Especially when a global epidemic in 2020 pressed the pause button on all walks of life, it had a huge impact on the operation of dialysis centers and the treatment of patients. Before the epidemic, in order to reduce the financial burden and reduce the impact on patients' normal lives, the United States had issued a presidential executive order to encourage 550,000 end-stage renal disease patients to receive home hemodialysis and promote the decentralization of hemodialysis. The trend of moving dialysis treatment settings from hospitals to homes is starting to pick up steam again in the industry. In China, in response to the huge supply gap for dialysis treatment, policies have provided guidance from various aspects such as medical device research and production, medical insurance cost control, and medical service construction. With the development of decentralized home hemodialysis, the demand for home hemodialysis machines will gradually increase in the future, and the home hemodialysis machine industry will develop rapidly.

Increased incidence of chronic kidney disease

The increasing incidence of chronic kidney disease is related to many factors. Global epidemiological studies of CKD show that the main cause of CKD is diabetes, followed by hypertension. The prevalence of CKD among diabetic patients is 30% to 40%, and approximately 40% of diabetic patients eventually develop diabetic kidney disease (DKD). Studies have found that the prevalence of CKD among adults with hypertension is about 30%. Long-term mental stress, lack of sleep, and fatigue can lead to the occurrence of high blood pressure, and high blood pressure is a high-risk factor for CKD. Therefore, occupations with stressful work, high concentration of attention, and a lot of physical activity will also increase the risk of CKD. increase in height. Data from the International Diabetes Federation (IDF) Diabetes Map show that the global prevalence of impaired glucose tolerance (IGT) among adults is 9.1%, with a population of 464 million. It is expected that this proportion will increase to 10.0% by 2045, affecting 640 million adults. In 2021, approximately 537 million adults (aged 20-79) worldwide will suffer from diabetes, and the global adult diabetes prevalence rate is approximately 10.5%. That is, 1 in every 10 people has diabetes. In 2021, the top three countries with the largest number of diabetic patients among people aged 20-79 are China, India and Pakistan. Among them, China has about 141 million people with diabetes, making it the country with the largest number of diabetes patients in the world. With the fast pace of modern society and high work intensity, people's activities are getting less and less, coupled with long-term unhealthy and irregular diet, there are more and more people suffering from high blood pressure and diabetes, plus some Drug abuse affects the risk of kidney disease. With the increasing number of patients with diabetes and hypertension around the world, and the influence of a series of factors, the incidence of chronic kidney disease may increase in the future, and the demand for home hemodialysis machines may increase.

Region Overview:

In 2022, the market share of North American home hemodialysis machines was 92.68%.

Company Overview:

NXSTAGE is one of the main participants in the domestic hemodiaplasm market, which has a 73.92%share in 2023.

NXSTAGE is an American medical technology company developing innovative products for the treatment of end -stage renal disease (ESRD) and acute renal failure for development, manufacturing and sales. Since its establishment, a small amount of dialysis clinic has been established to develop innovative nursing service models for patients with ending renal diseases.

Segmentation Overview:

Divided by type, low -throughput markets occupied the largest market share in 2022.

According to the hemodialysis machine's flux of the dialysis solution, it is divided into high -throughput household hemodialysis machines and low -handed home hemodialysis machines. The dialysis liquid flux is 500ml/min or more is a high -throughput household hemodialysis machine. Dialysis liquid flux is 500ml/min below low -throughput home hemodialysis machine.

Application Overview:

From the application point of view, the market segment of patients over 55 years old from 2018 to 2022 accounts for the largest share.

Key Companies in the global Home Hemodialysis Machine market covered in Chapter 3:

NxStage
Quanta Dialysis Technologies
Physidia
Outset Medical
Infomed

In Chapter 4 and Chapter 14.2, on the basis of types, the Home Hemodialysis Machine market from 2019 to 2030 is primarily split into:

low throughput
high throughput

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Home Hemodialysis Machine market from 2019 to 2030 covers:

Below 20 Years Old
20 to 40 Years Old
40 to 55 Years Old
Over 55 Years Old

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)